Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease

Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease

Patients with Type 2 diabetes mellitus (T2DM) and Chronic Kidney Disease (CKD) face an increased risk of morbidity and mortality after influenza infection. Several studies have shown that the influenza vaccine effectively prevents morbidity and mortality in T2DM patients. However, there has been lim...

Full description

Bibliographic Details
Main Authors: Henhen Heryaman, Cep Juli, Arnengsih Nazir, Mas Rizky A. A. Syamsunarno, Badrul Hisham Yahaya, Dewi Kartika Turbawaty, Rini Mulia Sari, Hikmat Permana, Rudi Supriyadi, Nur Atik
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Vaccines
Subjects:
clinical trial
immunogenicity
trivalent influenza vaccine
T2DM
T2DM–CKD
Online Access:https://www.mdpi.com/2076-393X/12/3/227

Internet

https://www.mdpi.com/2076-393X/12/3/227

Similar Items